IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $182,692 | -11.9% | 11,779 | +0.8% | 0.02% | -26.5% |
| Q4 2022 | $207,480 | +205.1% | 11,689 | -4.1% | 0.03% | +240.0% |
| Q3 2022 | $68,000 | -87.1% | 12,195 | -91.0% | 0.01% | -78.3% |
| Q2 2022 | $527,000 | -29.3% | 135,228 | 0.0% | 0.05% | -28.1% |
| Q1 2022 | $745,000 | -19.9% | 135,228 | +23.9% | 0.06% | -9.9% |
| Q4 2021 | $930,000 | -35.1% | 109,138 | -19.6% | 0.07% | -25.3% |
| Q2 2021 | $1,434,000 | – | 135,700 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |